A Prediction Model Based on Systemic Immune-Inflammatory Index Combined with Other Predictors for Major Adverse Cardiovascular Events in Acute Myocardial Infarction Patients

References

• Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. New Engl J Med. 2010;362(23):2155–2165. doi:10.1056/NEJMoa0908610
   PubMed Web of Science ®Google Scholar
• Wu X, Reboll MR, Korf-Klingebiel M, Wollert KC. Angiogenesis after acute myocardial infarction. Cardiovascul Res. 2021;117(5):1257–1273. doi:10.1093/cvr/cvaa287
   PubMed Web of Science ®Google Scholar
• Zellweger MJ, Kaiser C, Jeger R, et al. Coronary artery disease progression late after successful stent implantation. J Am College Cardiol. 2012;59:793–799. doi:10.1016/j.jacc.2011.11.024
   PubMed Web of Science ®Google Scholar
• Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36:1163–1170. doi:10.1093/eurheartj/ehu505
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2015;385:441–451. doi:10.1016/s0140-6736(14)60921-1
   PubMed Web of Science ®Google Scholar
• Murugiah K, Wang Y, Nuti SV, et al. Are non-ST-segment elevation myocardial infarctions missing in China? Eur Heart J Qual Care Clin Outcomes. 2017;3:319–327. doi:10.1093/ehjqcco/qcx025
   PubMedGoogle Scholar
• Holmstrom L, Chugh SS. How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation. Eur Heart J. 2022;43:4897–4898. doi:10.1093/eurheartj/ehac578
   PubMedGoogle Scholar
• Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Int Med. 2003;163:2345–2353. doi:10.1001/archinte.163.19.2345
   PubMed Web of Science ®Google Scholar
• Castro-Dominguez Y, Dharmarajan K, McNamara RL. Predicting death after acute myocardial infarction. Trend Cardiovasc Med. 2018;28:102–109. doi:10.1016/j.tcm.2017.07.011
   PubMed Web of Science ®Google Scholar
• Sincer I, Mansiroglu AK, Aktas G, Gunes Y, Kocak MZ. Association between hemogram parameters and coronary collateral development in subjects with non-ST-elevation myocardial infarction. Rev Assoc Med Bras. 2020;66(2):160–165. doi:10.1590/1806-9282.66.2.160
   PubMed Web of Science ®Google Scholar
• Sincer I, Gunes Y, Mansiroglu AK, Cosgun M, Aktas G. Association of mean platelet volume and red blood cell distribution width with coronary collateral development in stable coronary artery disease. Adv Int Cardiol. 2018;14(3):263–269. doi:10.5114/aic.2018.78329
   Google Scholar
• Sincer I, Gunes Y, Mansiroglu AK, Aktas G. Differential value of eosinophil count in acute coronary syndrome among elderly patients. Aging Male. 2020;23(5):958–961. doi:10.1080/13685538.2019.1643310
   PubMed Web of Science ®Google Scholar
• Aktas G. Association between the Prognostic Nutritional Index and Chronic Microvascular Complications in Patients with Type 2 Diabetes Mellitus. J Clin Med. 2023;12. doi: 10.3390/jcm12185952
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 2019;65(1):9–15. doi:10.1590/1806-9282.65.1.9
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67(4):549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87. doi:10.1016/j.pharmthera.2018.01.001
   PubMed Web of Science ®Google Scholar
• Westman PC, Lipinski MJ, Luger D, et al. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2016;67(17):2050–2060. doi:10.1016/j.jacc.2016.01.073
   PubMed Web of Science ®Google Scholar
• Song L, Zhao X, Chen R, et al. Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes. Cardiovasc Diabetol. 2022;21(1):80. doi:10.1186/s12933-022-01519-3
   PubMed Web of Science ®Google Scholar
• Burger PM, Dorresteijn JAN, Fiolet ATL, et al. Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease. Eur J Prev Cardiol. 2023;30(18):1950–1962. doi:10.1093/eurjpc/zwad221
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen S, Han Y, Xu Q, Zhao X. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are important indicators for predicting in-hospital death in elderly AMI patients. J Inflamm Res. 2023;16:2051–2061. doi:10.2147/jir.S411086
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177. doi:10.1093/eurheartj/ehx393
   PubMed Web of Science ®Google Scholar
• Machado GP, Araujo GN, Carpes CK, et al. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Atherosclerosis. 2018;274:212–217. doi:10.1016/j.atherosclerosis.2018.05.022
   PubMed Web of Science ®Google Scholar
• Zhang S, Diao J, Qi C, et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC Cardiovasc Disord. 2018;18:75. doi:10.1186/s12872-018-0812-6
   PubMed Web of Science ®Google Scholar
• Dentali F, Nigro O, Squizzato A, et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: a systematic review and meta-analysis of the literature. Int J Cardiol. 2018;266:31–37. doi:10.1016/j.ijcard.2018.02.116
   PubMed Web of Science ®Google Scholar
• Li XT, Fang H, Li D, et al. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction. Chin Med J. 2020;133:415–423. doi:10.1097/cm9.0000000000000650
   PubMed Web of Science ®Google Scholar
• Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015;12:305–312. doi:10.11909/j.issn.1671-5411.2015.03.020
   PubMedGoogle Scholar
• Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23. doi:10.3390/ijms23179553
   PubMedGoogle Scholar
• Taslamacioglu Duman T, Ozkul FN, Balci B. Could systemic inflammatory index predict diabetic kidney injury in type 2 diabetes mellitus? Diagnostics. 2023;13. doi:10.3390/diagnostics13122063
   Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138:e618–e651. doi:10.1161/cir.0000000000000617
   PubMed Web of Science ®Google Scholar
• Oki T, Ishii S, Takigami Y, et al. Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy. J Cardiol. 2022;79:358–364. doi:10.1016/j.jjcc.2021.10.010
   PubMed Web of Science ®Google Scholar
• Armillotta M, Amicone S, Bergamaschi L, et al. Predictive value of Killip classification in MINOCA patients. Eur J Intern Med. 2023;117:57–65. doi:10.1016/j.ejim.2023.08.011
   PubMed Web of Science ®Google Scholar
• Luo E, Wang D, Yan G, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovascul Diabetol. 2019;18:150. doi:10.1186/s12933-019-0957-3
   PubMed Web of Science ®Google Scholar
• Hicks KA, Tcheng JE, Bozkurt B, et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Circulation. 2015;132:302–361. doi:10.1161/cir.0000000000000156
   PubMed Web of Science ®Google Scholar
• Dharmarajan K, Li J, Li X, Lin Z, Krumholz HM, Jiang L. The China Patient-Centered Evaluative Assessment of Cardiac Events (China PEACE) retrospective study of acute myocardial infarction: study design. Circ Cardiovasc Qual Outcomes. 2013;6:732–740. doi:10.1161/circoutcomes.113.000441
   PubMed Web of Science ®Google Scholar
• Wu C, Huo X, Liu J, et al. Development and validation of a risk prediction model for in-hospital major cardiovascular events in patients hospitalised for acute myocardial infarction. BMJ open. 2021;11:e042506. doi:10.1136/bmjopen-2020-042506
   PubMed Web of Science ®Google Scholar
• Björkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185:1630–1645. doi:10.1016/j.cell.2022.04.004
   PubMed Web of Science ®Google Scholar
• Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5:56. doi:10.1038/s41572-019-0106-z
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124:315–327. doi:10.1161/circresaha.118.313591
   PubMed Web of Science ®Google Scholar
• Chen Y, Li X, Lin X, et al. Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis. Thromb J. 2022;20:24. doi:10.1186/s12959-022-00384-0
   PubMed Web of Science ®Google Scholar
• Harrington RA. Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377:1197–1198. doi:10.1056/NEJMe1709904
   PubMed Web of Science ®Google Scholar
• Wirtz PH, von Känel R. Psychological stress, inflammation, and coronary heart disease. Curr Cardiol Rep. 2017;19:111. doi:10.1007/s11886-017-0919-x
   PubMed Web of Science ®Google Scholar
• Kelesoglu S, Yilmaz Y, Elcık D. Relationship between C-reactive protein to albumin ratio and coronary collateral circulation in patients with stable coronary artery disease. Angiology. 2021;72:829–835. doi:10.1177/00033197211004392
   PubMed Web of Science ®Google Scholar
• Aday AW, Bagheri M, Vaitinadin NS, Mosley JD, Wang TJ. Polygenic risk score in comparison with C-reactive protein for predicting incident coronary heart disease. Atherosclerosis. 2023;379:117194. doi:10.1016/j.atherosclerosis.2023.117194
   PubMed Web of Science ®Google Scholar
• Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887–896. doi:10.1084/jem.20012044
   PubMed Web of Science ®Google Scholar
• Pfeiler S, Stark K, Massberg S, Engelmann B. Propagation of thrombosis by neutrophils and extracellular nucleosome networks. Haematologica. 2017;102:206–213. doi:10.3324/haematol.2016.142471
   PubMed Web of Science ®Google Scholar
• Trakarnwijitr I, Li B, Adams H, Layland J, Garlick J, Wilson A. Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery disease. Int J Cardiol. 2017;248:349–354. doi:10.1016/j.ijcard.2017.06.127
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aurora RG, Siswanto BB, Muliawan HS. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis. 2022;33:137–143. doi:10.1097/mca.0000000000001040
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212–6222. doi:10.1158/1078-0432.Ccr-14-0442
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Kelesoglu S, Kalay N. A novel predictor of contrast-induced nephropathy in patients with carotid artery disease; the systemic immune inflammation index. Angiology. 2022;73:781–787. doi:10.1177/00033197211061919
   PubMed Web of Science ®Google Scholar
• Kelesoglu S, Yilmaz Y, Elcik D, et al. Increased serum systemic immune-inflammation index is independently associated with severity of carotid artery stenosis. Angiology. 2023;74:790–797. doi:10.1177/00033197221144934
   PubMed Web of Science ®Google Scholar
• Kelesoglu S, Yilmaz Y, Elcık D, et al. Systemic immune inflammation index: a novel predictor of contrast-induced nephropathy in patients with Non-ST segment elevation myocardial infarction. Angiology. 2021;72:889–895. doi:10.1177/00033197211007738
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Kelesoglu S, Elcik D, Ozmen R, Kalay N. Predictive values of systemic immune-inflammation index in new-onset atrial fibrillation following coronary artery bypass grafting. Braz J Cardiovasc Surg. 2023;38:96–103. doi:10.21470/1678-9741-2021-0278
   PubMed Web of Science ®Google Scholar
• Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50:e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Huang J, Zhang Q, Wang R, et al. Systemic immune-inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention. Med Sci Monit. 2019;25:9690–9701. doi:10.12659/msm.919802
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye T, Chen K, et al. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis. Front Cardiovasc Med. 2022;9:966299. doi:10.3389/fcvm.2022.966299
   PubMedGoogle Scholar
• Moledina SM, Kontopantelis E, Wijeysundera HC, et al. Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study. Eur Heart J. 2022;43:2289–2299. doi:10.1093/eurheartj/ehac052
   PubMedGoogle Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–1367. doi:10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Meune C, Drexler B, Haaf P, et al. The GRACE score’s performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Heart. 2011;97:1479–1483. doi:10.1136/hrt.2010.220988
   PubMed Web of Science ®Google Scholar